54 Results for "

pumilacidin

" in MedChemExpress (MCE) Product Catalog:
Products (54)

54 Results for "pumilacidin" in MCE Product Catalog:

Cat. No.: HY-169089
Target:  

Drug Derivative

Domaines de recherche:  

Cancer

RP-182-PEG3-K palmitic acid-NH2 (Compound 1a) is a fatty acid derivative of the immunomodulatory peptide RP-182. RP-182-PEG3-K palmitic acid-NH2 inhibits CD206 high M2-like macrophage (IC50 of 3.2 μM) and induces phagocytosis. RP-182-PEG3-K palmitic acid-NH2 exhibits antitumor efficacy in mouse B16 melanoma allografts .
Cat. No.: HY-P10563
CAS No.: 2580150-96-3
Synonyms: BHV-1100
Target:  

CD38 IFNAR

Domaines de recherche:  

Cancer

Noraramtide (BHV-1100) is an antibody-recruiting molecule. Noraramtide binds to CD38 and recruits natural killer (NK) cells to mediate antibody-dependent cellular cytotoxicity. Noraramtide enhances the capacity of autologous cytokine-induced memory-like (CIML) NK cells to produce IFNγ and CD107a, thereby improving their cytotoxicity against multiple myeloma cells. Noraramtide can be used in the research of multiple myeloma .
Cat. No.: HY-P11233
CAS No.: 2377239-31-9
Target:  

GLP Receptor

Domaines de recherche:  

Metabolic Disease

Acmopatide (Compound E-153) is a dual-acting GIP/GLP-1 receptor agonist. Acmopatide is used in anti-diabetic research .
Cat. No.: HY-P0014AS
Domaines de recherche:  

Metabolic Disease

Liraglutide-d8 tetraTFA is deuterium labeled Liraglutide (HY-P0014). Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the study of type 2 diabetes mellitus .
Cat. No.: HY-P10031A
Target:  

GLP Receptor GCGR

Domaines de recherche:  

Metabolic Disease

SAR441255 TFA is a GLP-1R/GCGR/GIPR agonist, with human EC50 values of 1.03 pM, 1.01 pM, and 0.73 pM, respectively. SAR441255 TFA stimulates receptor activity and drives cAMP accumulation. SAR441255 TFA can be used for the research of type 2 diabetes, obesity .
Cat. No.: HY-169089A
Target:  

Drug Derivative

Domaines de recherche:  

Cancer

RP-182-PEG3-K(palmitic acid)-NH2 (Compound 1a) TFA is a fatty acid derivative of the immunomodulatory peptide RP-182. RP-182-PEG3-K(palmitic acid)-NH2 TFA inhibits CD206 high M2-like macrophage (IC50 of 3.2 μM) and induces phagocytosis. RP-182-PEG3-K(palmitic acid)-NH2 TFA exhibits antitumor efficacy in mouse B16 melanoma allografts .
Cat. No.: HY-P0014A
CAS No.: 1997361-86-0
Target:  

GLP Receptor

Domaines de recherche:  

Metabolic Disease

Liraglutide acetate is the acetate form of Liraglutide (HY-P0014), a glucagon-like peptide-1 (GLP-1) receptor agonist studied in type 2 diabetes .
Cat. No.: HY-P10318
Target:  

GLP Receptor

Domaines de recherche:  

Endocrinology

SHR-2042 is a selective agonist of the GLP-1 receptor.SHR-2042 improves glycemic control by activating the GLP-1 receptor, enhancing insulin secretion and inhibiting glucagon secretion. SHR-2042 combined with sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC) promotes monomerization through the formation of micelles and improves oral absorption efficiency .
Cat. No.: HY-P1614
CAS No.: 1026276-22-1
ZEP-3 is a tetrapeptide derivative with anti-aging activity for the skin. ZEP-3 can inhibit ROS production and alleviate oxidative stress .
Cat. No.: HY-P0041A
Target:  

Vasopressin Receptor

Domaines de recherche:  

Neurological Disease

F992 TFA is an antidiuretic peptide and vasopressin (antidiuretic hormone) analogue .
Cat. No.: HY-P0014S2
Domaines de recherche:  

Others

Liraglutide- 13C6, 15 TFA is the 13C and 15N labeledLiraglutide(HY-P0014). Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the study of type 2 diabetes mellitus .
Cat. No.: HY-P3143A
Target:  

PD-1/PD-L1

Domaines de recherche:  

Cancer

BMSpep-57 hydrochloride is a potent and competitive macrocyclic peptide inhibitor of PD-1/PD-L1 interaction with an IC50 of 7.68 nM. BMSpep-57 hydrochloride binds to PD-L1 with Kds of 19 nM and 19.88 nM in MST and SPR assays, respectively. BMSpep-57 hydrochloride facilitates T cell function by in creasing IL-2 production in PBMCs .
Cat. No.: HY-113560
CAS No.: 103955-73-3
Domaines de recherche:  

Infection

Plipastatin B1 is a lipopeptide antibiotic, an inhibitor of phospholipase A2 (PLA2), which has antifungal activity .
Cat. No.: HY-P1162
CAS No.: 73168-24-8
Synonyms: SKF 100273
Target:  

Vasopressin Receptor

Domaines de recherche:  

Metabolic Disease

(d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin (SKF 100273) is a vasopressin V1 receptor selective antagonist .
Cat. No.: HY-P10910
CAS No.: 2919344-88-8
Target:  

GLP Receptor

Domaines de recherche:  

Metabolic Disease

Vensemaglutide is the agonist for glucagon-like peptide 1 (GLP-1) receptor. Vensemaglutide can be used in research of diabetes or other metabolic disorders .
Cat. No.: HY-P11243
Target:  

Ephrin Receptor

Domaines de recherche:  

Neurological Disease

EphA4 agonist compound 23 is a novel EphA4 agonist peptide mimic. EphA4 agonist compound 23 exhibits high affinity, high selectivity, and significant receptor activation ability. EphA4 agonist compound 23 is commonly used in the study of neurodegenerative diseases .
Cat. No.: HY-P10876
Target:  

Amyloid-β

Domaines de recherche:  

Neurological Disease

mcK6A1 is an inhibitor for the aggregation of amyloid-β (), that selectively binds to the 16KLVFFA21 segment of Aβ42, forms an extended β-folded structure, and inhibits the formation of Aβ42 oligomers. mcK6A1 can be used in research of Alzheimer's disease and other amyloid-related diseases .
Cat. No.: HY-P4837
CAS No.: 220341-79-7
Target:  

Peptides

Domaines de recherche:  

Others

Ac-Lys-D-Ala-D-lactic acid is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development .
Cat. No.: HY-P10200
CAS No.: 3032621-32-9
Target:  

Bacterial

Domaines de recherche:  

Infection

CP7-FP13-2 is a peptide with antivirulence factor and antibacterial activity. CP7-FP13-2 inhibits the formation of Staphylococcus aureus biofilm and has good antibacterial efficacy in mice .
Cat. No.: HY-P0041
CAS No.: 162277-99-8
Target:  

Vasopressin Receptor

Domaines de recherche:  

Neurological Disease

F992 is an antidiuretic peptide and vasopressin (antidiuretic hormone) analogue .